148 related articles for article (PubMed ID: 9402966)
21. Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism.
Glaser B; Furth J; Stanley CA; Baker L; Thornton PS; Landau H; Permutt MA
Hum Mutat; 1999; 14(1):23-9. PubMed ID: 10447255
[TBL] [Abstract][Full Text] [Related]
22. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
[TBL] [Abstract][Full Text] [Related]
23. Striking founder effect for the fragile X syndrome in Finland.
Oudet C; von Koskull H; Nordström AM; Peippo M; Mandel JL
Eur J Hum Genet; 1993; 1(3):181-9. PubMed ID: 8044645
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of myotonic dystrophy in Israeli Jewish communities: inter-community variation and founder premutations.
Segel R; Silverstein S; Lerer I; Kahana E; Meir R; Sagi M; Zilber N; Korczyn AD; Shapira Y; Argov Z; Abeliovich D
Am J Med Genet A; 2003 Jun; 119A(3):273-8. PubMed ID: 12784291
[TBL] [Abstract][Full Text] [Related]
25. Y chromosome evidence for a founder effect in Ashkenazi Jews.
Nebel A; Filon D; Faerman M; Soodyall H; Oppenheim A
Eur J Hum Genet; 2005 Mar; 13(3):388-91. PubMed ID: 15523495
[TBL] [Abstract][Full Text] [Related]
26. Haplotype analysis at the FRAXA locus in the Japanese population.
Richards RI; Kondo I; Holman K; Yamauchi M; Seki N; Kishi K; Staples A; Sutherland GR; Hori T
Am J Med Genet; 1994 Jul; 51(4):412-6. PubMed ID: 7943009
[TBL] [Abstract][Full Text] [Related]
27. No evidence from genome-wide data of a Khazar origin for the Ashkenazi Jews.
Behar DM; Metspalu M; Baran Y; Kopelman NM; Yunusbayev B; Gladstein A; Tzur S; Sahakyan H; Bahmanimehr A; Yepiskoposyan L; Tambets K; Khusnutdinova EK; Kushniarevich A; Balanovsky O; Balanovsky E; Kovacevic L; Marjanovic D; Mihailov E; Kouvatsi A; Triantaphyllidis C; King RJ; Semino O; Torroni A; Hammer MF; Metspalu E; Skorecki K; Rosset S; Halperin E; Villems R; Rosenberg NA
Hum Biol; 2013 Dec; 85(6):859-900. PubMed ID: 25079123
[TBL] [Abstract][Full Text] [Related]
28. Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.
Laitman Y; Feng BJ; Zamir IM; Weitzel JN; Duncan P; Port D; Thirthagiri E; Teo SH; Evans G; Latif A; Newman WG; Gershoni-Baruch R; Zidan J; Shimon-Paluch S; Goldgar D; Friedman E
Eur J Hum Genet; 2013 Feb; 21(2):212-6. PubMed ID: 22763381
[TBL] [Abstract][Full Text] [Related]
29. Analysis of FMR1 and flanking microsatellite markers in normal and fragile X chromosomes in Portugal: evidence for a "protector" haplotype.
Peixoto A; dos Santos MR; Seruca R; Amorim A; Castedo S
Eur J Hum Genet; 1998; 6(5):518-22. PubMed ID: 9801877
[TBL] [Abstract][Full Text] [Related]
30. Extended Y chromosome haplotypes resolve multiple and unique lineages of the Jewish priesthood.
Hammer MF; Behar DM; Karafet TM; Mendez FL; Hallmark B; Erez T; Zhivotovsky LA; Rosset S; Skorecki K
Hum Genet; 2009 Nov; 126(5):707-17. PubMed ID: 19669163
[TBL] [Abstract][Full Text] [Related]
31. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
[TBL] [Abstract][Full Text] [Related]
32. Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. The French FMF Consortium.
Am J Hum Genet; 1996 Sep; 59(3):603-12. PubMed ID: 8751861
[TBL] [Abstract][Full Text] [Related]
33. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.
Eichler EE; Macpherson JN; Murray A; Jacobs PA; Chakravarti A; Nelson DL
Hum Mol Genet; 1996 Mar; 5(3):319-30. PubMed ID: 8852655
[TBL] [Abstract][Full Text] [Related]
34. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.
Gallione CJ; Solatycki A; Awad IA; Weber JL; Marchuk DA
Genet Med; 2011 Jul; 13(7):662-6. PubMed ID: 21543988
[TBL] [Abstract][Full Text] [Related]
35. Reconstruction of patrilineages and matrilineages of Samaritans and other Israeli populations from Y-chromosome and mitochondrial DNA sequence variation.
Shen P; Lavi T; Kivisild T; Chou V; Sengun D; Gefel D; Shpirer I; Woolf E; Hillel J; Feldman MW; Oefner PJ
Hum Mutat; 2004 Sep; 24(3):248-60. PubMed ID: 15300852
[TBL] [Abstract][Full Text] [Related]
36. Distribution of FMR-1 and associated microsatellite alleles in a normal Chinese population.
Zhong N; Liu X; Gou S; Houck GE; Li S; Dobkin C; Brown WT
Am J Med Genet; 1994 Jul; 51(4):417-22. PubMed ID: 7943010
[TBL] [Abstract][Full Text] [Related]
37. Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.
Colombo R
Am J Hum Genet; 2000 Feb; 66(2):692-7. PubMed ID: 10677327
[TBL] [Abstract][Full Text] [Related]
38. An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews.
Zelinger L; Greenberg A; Kohl S; Banin E; Sharon D
Hum Genet; 2010 Sep; 128(3):261-7. PubMed ID: 20549516
[TBL] [Abstract][Full Text] [Related]
39. Haplotype Analysis of DXS548 and FRAXAC1 Microsatellite Loci in Iranian Patients with Fragile X Syndrome.
Aleyasin SA; Salamat F; Mirakhori M
Iran J Child Neurol; 2018; 12(1):36-46. PubMed ID: 29379561
[TBL] [Abstract][Full Text] [Related]
40. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes.
Oudet C; Mornet E; Serre JL; Thomas F; Lentes-Zengerling S; Kretz C; Deluchat C; Tejada I; Boué J; Boué A
Am J Hum Genet; 1993 Feb; 52(2):297-304. PubMed ID: 8094266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
